Regeneron Pharmaceuticals stockREGN
Regeneron Pharmaceuticals trades at $902.90, 9.0% below its 52-week high (Nov 4, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +17.3% year to date, +40.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Jan 29, 2027.
Ratings, candles, signals and the screener for REGN — after you log in
Open the terminalFrequently asked questions about Regeneron Pharmaceuticals
What is the Regeneron Pharmaceuticals stock price?
At the close on Nov 5, 2026: $902.90 (−2.98% on the day). 52-week high: $991.73 on Nov 4, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Regeneron Pharmaceuticals report earnings?
The next quarterly report is on Jan 29, 2027. Last quarter, earnings per share changed +70% year over year, revenue +36%.
Does Regeneron Pharmaceuticals pay dividends?
Yes, the dividend yield is about 0.41% a year.
Where does Regeneron Pharmaceuticals trade and how to buy it?
Ticker REGN, exchange Nasdaq, listed since 1991. You can buy it through a broker with access to US exchanges.
Should I buy Regeneron Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for REGN are in the terminal after you log in.